Haematology
Service
Pfizer (United States)
Nueva York, Estados UnidosPublications in collaboration with researchers from Pfizer (United States) (3)
2017
-
Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in spain
ClinicoEconomics and Outcomes Research, Vol. 9, pp. 39-47
2011
-
Prophylaxis therapy in haemophilia A: Current situation in Spain
Haemophilia, Vol. 17, Núm. 1, pp. 75-80
1996
-
Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis
Thrombosis and Haemostasis, Vol. 76, Núm. 2, pp. 195-199